Moneycontrol
HomeNewsIndiaCOVID-19 Vaccine Update: Nearly 12 crore jabs to be available for vaccination in June, says health ministry
Trending Topics

COVID-19 Vaccine Update: Nearly 12 crore jabs to be available for vaccination in June, says health ministry

The delivery schedule for this allocation of COVID-19 vaccine will be shared in advance, said the health ministry.

May 30, 2021 / 12:20 IST
Story continues below Advertisement
In May, a total number of 7,94,05,200 doses were available for the national COVID-19 vaccination programme. (Representative image: Reuters)

To vaccinate people against the novel coronavirus infection nearly 12 crore vaccine doses will be available in states and union territories in June through the free of cost channel and direct state procurement said the Union Health Ministry on May 30.

As part of the nationwide vaccination drive, the central government has been providing COVID vaccines to the states and UTs free of cost. On May 1, it implemented the 'Liberalized Pricing and Accelerated National COVID-19 Vaccination Strategy' wherein 50 percent of the available doses are earmarked for supply to states and UTs, as free of cost supply from the Centre, while the remaining is available for direct procurement from the vaccine manufacturers by states, UTs and private hospitals.

Story continues below Advertisement

In June, 6.09 crore (6,09,60,000) doses of COVID vaccines will be supplied to the states and UTs for vaccination of priority group of healthcare workers (HCWs), frontline workers (FLWs) and people aged 45 years and above as free of cost from the Centre, said the ministry in a release issued on the day.

Follow our LIVE blog for the latest updates of the novel coronavirus pandemic

COVID-19 Vaccine
Frequently Asked Questions

View more

How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.
View more
+ Show